W
IPCI

WealthShield’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

WealthShield’s Portfolio IPCI Stock Details IPCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$14K Buy
+1,650
New +$15K 0.01% 188

Other funds holding IPCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
FFA
First Foundation Advisors Irvine, California $2.78B AUM 23.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ATC
Argent Trust Co Nashville, Tennessee $3.46B AUM 30.37% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return
VAM
Verity Asset Management Durham, North Carolina $264M AUM 28.52% 1-Year Est. Return

WealthShield's IPCI Position: Q4 2017 in Review

WealthShield opened a new position in Intellipharmaceuticals International Inc. (IPCI) in Q4 2017: 1,650 shares worth $14K. The stake represents 0.01% of the portfolio and ranks #188 among its holdings.

28 funds tracked by Wall St. Rank hold IPCI as of Q4 2017.

  • WealthShield held 1,650 shares of Intellipharmaceuticals International Inc. worth $14K as of Q4 2017.
  • Intellipharmaceuticals International Inc. was a new WealthShield position in Q4 2017.
  • Intellipharmaceuticals International Inc. made up 0.01% of WealthShield's portfolio in Q4 2017, its #188 holding.
  • 28 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q4 2017.

Based on WealthShield's 13F filing for Q4 2017, filed 14 Feb 2018.